首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   72119篇
  免费   6641篇
  国内免费   2139篇
耳鼻咽喉   663篇
儿科学   1398篇
妇产科学   2283篇
基础医学   11909篇
口腔科学   1442篇
临床医学   7397篇
内科学   11367篇
皮肤病学   2103篇
神经病学   2927篇
特种医学   2361篇
外国民族医学   7篇
外科学   8105篇
综合类   7913篇
现状与发展   9篇
一般理论   7篇
预防医学   5594篇
眼科学   614篇
药学   5963篇
  40篇
中国医学   1140篇
肿瘤学   7657篇
  2024年   107篇
  2023年   1167篇
  2022年   1920篇
  2021年   2853篇
  2020年   2972篇
  2019年   2877篇
  2018年   2689篇
  2017年   2767篇
  2016年   3074篇
  2015年   3111篇
  2014年   4664篇
  2013年   5455篇
  2012年   3952篇
  2011年   4309篇
  2010年   3498篇
  2009年   3355篇
  2008年   3220篇
  2007年   3146篇
  2006年   2918篇
  2005年   2604篇
  2004年   2387篇
  2003年   2187篇
  2002年   1899篇
  2001年   1655篇
  2000年   1447篇
  1999年   1208篇
  1998年   1104篇
  1997年   967篇
  1996年   880篇
  1995年   791篇
  1994年   796篇
  1993年   599篇
  1992年   648篇
  1991年   475篇
  1990年   430篇
  1989年   379篇
  1988年   359篇
  1987年   246篇
  1986年   237篇
  1985年   338篇
  1984年   277篇
  1983年   134篇
  1982年   139篇
  1981年   153篇
  1980年   150篇
  1979年   108篇
  1978年   81篇
  1977年   53篇
  1976年   54篇
  1975年   20篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
OBJECTIVE: To evaluate variations in prenatal care quality by public and private clinical settings and by household wealth. DESIGN: The study uses 2003 data detailing retrospective reports of 12 prenatal care procedures received that correspond to clinical guidelines. The 12 procedures are summed up, and prenatal care quality is described as the average procedures received by clinical setting, provider qualifications, and household wealth. SETTING: Low-income communities in 17 states in urban Mexico. PARTICIPANTS: A total of 1253 women of reproductive age who received prenatal care within 1 year of the survey. MAIN OUTCOME MEASURE: The mean of the 12 prenatal care procedures received, reported as unadjusted and adjusted for individual, household, and community characteristics. RESULTS: Women received significantly more procedures in public clinical settings [80.7, 95% confidence interval (CI) = 79.3-82.1; P < or = 0.05] compared with private (60.2, 95% CI = 57.8-62.7; P < or = 0.05). Within private clinical settings, an increase in household wealth is associated with an increase in procedures received. Care from medical doctors is associated with significantly more procedures (78.8, 95% CI = 77.5-80.1; P < or = 0.05) compared with non-medical doctors (50.3, 95% CI = 46.7-53.9; P < or = 0.05). These differences are independent of individual, household, and community characteristics that affect health-seeking behavior. CONCLUSIONS: Significant differences in prenatal care quality exist across clinical settings, provider qualifications, and household wealth in urban Mexico. Strategies to improve quality include quality reporting, training, accreditation, regulation, and franchising.  相似文献   
102.
Current medical procedures used in prenatal screening and diagnosis of handicapping conditions are reviewed. These strategies include ultrasound, amniocentesis, chorionic villus biopsy, restriction enzyme analysis, maternal serum analysis, fetoscopy, and fetal serum analysis. Along with an explanation of each method, advantages, disadvantages, and risks involved with each are provided. An understanding of these procedures by medical and educational personnel is encouraged, and the potential benefits of prenatal identification of handicapping conditions are emphasized.  相似文献   
103.
Monohalogenated methanes (methyl chloride, methyl bromide and methyl iodide) are mutagenic and carcinogenic. The possible mechanism of these effects, DNA methylation, was studied. DNA adducts from orgnas of F344 rats exposed to these chemicals were separated and identified with high performance liquid chromatography (HPLC) and gaschro-matography/massspectrometry (GC/ MS). DNA adducts, 7-methylguanine (7-MeG) and O6-Methylguanine(08-MeG), incorporation of14C into de novo synthesis of nucleobases could be observed in enzymatic DNA hydrolysates by HPLC and determination of the radioactivity in the fractions. The formation of DNA add,ue,ts in the studied organs was only quantitatively different. The formation of O6-MeG was further pioved by analysing the acidic hydrolysates using HPLC with non-radioactive O6MeG as internal standard. 7-MeG and 3-MeA were identified with GC/MS analysis.  相似文献   
104.
从感染病毒乳鼠脑组织提取总RNA,采用RT-PCR和分子克隆技术将扩增到的G2糖蛋白基因插入含CMV启动子的pcDNA3.1/His质粒载体中,通过脂质体介导转染COS-7细胞,用SDS-PAGE、Western-blot及IFIA方法分别测定表达产物的相对分子量及特异性。结果证明获得正向插入的G2-pcDNA3.1/His重组表达质粒,表达产物的相对分子量为56ku,与理论预期大小一致,并且可与汉坦病毒H8205株的腹水抗体起特异反应。表明构建的G2-pcDNA3.1/His重组质粒所表达的蛋白为中国汉坦病毒株特有,能在哺乳动物细胞中表达并具有抗原性,重组质粒可应用于汉坦病毒的DNA疫苗研究。  相似文献   
105.
采用淋巴细胞分离液分离外周血中的有核细胞,经细胞裂解液处理,上清提取RNA,沉淀提取DNA,用分离液分离所得红细胞沉淀制备血红蛋白溶液。经对抽提物质量进行评价,发现3种提取物质量均高。本法能从少量外周血中同时分离DNA、RNA及血红蛋白,高效易操作,值得推广。  相似文献   
106.
碱性成纤维细胞生长因子对慢性鼓膜穿孔愈合的影响   总被引:2,自引:0,他引:2  
目的 :探讨碱性成纤维细胞生长因子 (bFGF)在慢性鼓膜穿孔愈合中的作用。方法 :在豚鼠慢性创伤性鼓膜穿孔的动物模型上 ,观察应用bFGF 磷酸缓冲液 (2 5 0mg/L)治疗的鼓膜愈合率 ,用组织学检查鼓膜中层厚度 ,并与仅用磷酸缓冲液 (PBS)处理的作对照。结果 :bFGF治疗组鼓膜愈合率明显高于PBS组 (89.3%vs 37.5 % ,P <0 .0 1) ;鼓膜中层厚度bFGF组显著高于PBS组 [(30 5± 37) μmvs (10 2± 2 1) μm ,P <0 .0 1]。结论 :局部应用bFGF有明显促进慢性鼓膜穿孔鼓膜中层厚度及上皮细胞增生 ,促进鼓膜愈合的作用。  相似文献   
107.
设计并试制了一种药用胶带纸层厚度在线检测系统.该系统将高精度电容传感器与计算机结合起来,同时配有丰富的外围器件,实现了多种实际生产中所需要的功能.它的出现,彻底解决了药用胶带纸胶层厚度在线检测这个难题,经过两年多的实际应用的检验,该系统实现了在线非接触测量,精度高,动态性能好,实现功能全面,价格合理,是药用胶带纸生产的必备检测仪器.由于该系统还可以很方便在纸张、塑料薄膜等其它生产线上进行推广,因而,其应用前景十分看好.  相似文献   
108.
目的探讨p16基因突变在白血病发生中的作用及基因突变的机制。方法利用点突变检测仪、水平和垂直板电泳对p16基因的外显子1、外显子2的PCR扩增产物作缺失和点突变分析。结果在白血病35例临床标本中有22例发生缺失突变,6例发生点突变,突变率约80%。在22例缺失突变病例中,有10例为不完全缺失突变即有低于外显子509bp的扩增产物。结论p16基因含有“GC”DNA重复顺序,易发生DNA重组及易位和重排。在白血病发生中起重要作用  相似文献   
109.
目的应用基因芯片研究三氧化二砷(As2O3)处理前后K562细胞基因表达的变化.方法提取As2O3处理前后K562细胞的总RNA,纯化为mRNA后再反转录为cDNA.cDNA经限制性内切酶Sau3AI切割后,cDNA片段分别用Cy3和Cy5标记,与自制的包含348个基因片段的胎盘库芯片杂交.结果杂交结果经扫描和软件分析,发现了11个差异表达的基因片段,其中有3个基因片段与细胞凋亡密切相关.结论我们构建的胎盘库基因芯片可以成功地用于研究药物作用前后基因表达的变化.  相似文献   
110.
The influence of left ventricular volume variations and regurgitant fraction variations upon left ventricular ejection fraction, during exercise was examined using equilibrium radionuclide angiography in patients suffering from aortic regurgitation. Ejection fraction (EF), regurgitant fraction (RF), end diastolic volume (EDV) and end systolic volume (ESV) variations from rest to peak exercise were determined in 44 patients suffering from chronic aortic regurgitation (AR) and in 8 healthy volunteers (C). In C, EF increased (+0.10±0.03, P<0.01) and ESV decreased significantly (-23%±12%, P<0.01) RF and EDV did not vary significantly. In AR patients, EF, EDV and ESV did not vary significantly because of important scattering of individual values. Changes in EF and ESV were inversely correlated (r=-0.79, P<0.01) and RF decreased significantly (-0.12±0.10, P<0.01). Volumes and EF changes during exercise occurred in three different ways. In a 1st subgroup of 7 patients, EF increased (+0.09±0.03, P<0.05) in conjunction with a reduction of ESV (-24%±12%, P<0.05) without a significant change in EDV. In a 2nd group of 22 patients. EF decreased (-0.04±0.07, P<0.01) in association with an increase in ESV (+17%±16%, P<0.01) and no change in EDV. In a 3rd subgroup of 15 patients, EF decreased (-0.02±0.06, P<0.01) despite a reduction in ESV (-7%±6%, P<0.01) because of a dramatic EDV decrease (-10%±6%, P<0.05). In this subgroup, changes in EF were inversely correlated with changes in ESV (r=-0.55, P<0.01) and positively related to EDV variations (r=0.42, P=0.02). EDV related to EDV variations (r=0.42, P=0.02). EDV changes were weakly, but significantly, correlated to RF decrease (r=0.39, P<0.05). We conclude that changes in left ventricular ejection fraction during exercise in patients with chronic aortic regurgitation are significantly related in some patients to changes in ventricular loading conditions as well as contractile state. Therefore, a correct interpretation of EF changes during exercise requires the simultaneous determination of changes in LV volumes.Abbreviations EDV end diastolic volume - EF ejection fraction - ESV end systolic volume - LV left ventricle - RV right ventricle  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号